Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)
- $700,000
- 1
- Oct 9, 2026
Official announcement on Grants.gov · opens the funder's page. Always confirm dates there.
Summary
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute invites applications to the Carcinogen Hazard Assessment Monographs Program (CHAMP) Initiative . NCI seeks meritorious proposals to critically and systematically evaluate the scientific evidence on carcinogenic hazards to humans…
Preparing an application?
On Plus, $39 a month
- The eligibility check against your profile: career stage, institution type, and the windows that close before the deadline does
More from National Institutes of Health
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)
$375k
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U01 Clinical Trial Optional)
Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)
Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
$375k
Related by subject
Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)
Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)
NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed)
$500k